Prognostic markers in young patients with premature coronary heart disease

Atherosclerosis

Volumn 224, Issue 1, 2012, Pages 213-217

  van Loon, Janine E ^a   de Maat, Moniek P M ^a   Deckers, Jaap W ^a   van Domburg, Ron T ^a   Leebeek, Frank W G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Fibrinogen; Premature coronary heart disease; Prognosis; Prognostic markers; Recurrent events; Risk factors; Von Willebrand factor

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; STATIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; DATA ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SURVIVAL; THROMBOSIS;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; VON WILLEBRAND FACTOR;

EID: 84865357032     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.06.067     Document Type: Article

References (26)

1. Zimmerman F.H., Cameron A., Fisher L.D., Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery study registry). J Am Coll Cardiol 1995, 26:654-661.
2. Choudhury L., Marsh J.D. Myocardial infarction in young patients. Am J Med 1999, 107:254-261.
3. Strong J.P., Malcom G.T., McMahan C.A., Tracy R.E., Newman W.P., Herderick E.E., et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. J Am Med Assoc 1999, 281:727-735.
4. Chouhan L., Hajar H.A., Pomposiello J.C. Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years. Am J Cardiol 1993, 71:157-159.
5. Hoit B.D., Gilpin E.A., Henning H., Maisel A.A., Dittrich H., Carlisle J., et al. Myocardial infarction in young patients: an analysis by age subsets. Circulation 1986, 74:712-721.
6. Malmberg K., Bavenholm P., Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 1994, 24:592-599.
7. Cole J.H., Miller J.I., Sperling L.S., Weintraub W.S. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 2003, 41:521-528.
8. Whincup P.H., Danesh J., Walker M., Lennon L., Thomson A., Appleby P., et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002, 23:1764-1770.
9. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
10. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998, 97:2007-2011.
11. Fibrinogen Studies C., Danesh J., Lewington S., Thompson S.G., Lowe G.D., Collins R., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005, 294:1799-1809.
12. de Bruijne E.L., Gils A., Guimaraes A.H., Dippel D.W., Deckers J.W., van den Meiracker A.H., et al. The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study. J Thromb Haemost 2009, 7:919-927.
13. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen] Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957, 17:237-246.
14. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006, 47:962-968.
15. Suleiman M., Aronson D., Reisner S.A., Kapeliovich M.R., Markiewicz W., Levy Y., et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003, 115:695-701.
16. Zebrack J.S., Anderson J.L., Maycock C.A., Horne B.D., Bair T.L., Muhlestein J.B., et al. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002, 89:145-149.
17. Mega J.L., Morrow D.A., De Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004, 44:335-339.
18. Nikfardjam M., Mullner M., Schreiber W., Oschatz E., Exner M., Domanovits H., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 2000, 247:341-345.
19. Harb T.S., Zareba W., Moss A.J., Ridker P.M., Marder V.J., Rifai N., et al. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol 2002, 89:216-221.
20. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and Disabilities angina pectoris study group. N Engl J Med 1995, 332:635-641.
21. Pineda J., Marin F., Marco P., Roldan V., Valencia J., Ruiz-Nodar J.M., et al. The prognostic value of biomarkers after a premature myocardial infarction. Int J Cardiol 2010, 143:249-254.
22. Spiel A.O., Gilbert J.C., Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 2008, 117:1449-1459.
23. Esmon C.T., Xu J., Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011, 9(Suppl. 1):182-188.
24. Lind P., Hedblad B., Stavenow L., Janzon L., Eriksson K.F., Lindgarde F. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol 2001, 21:452-458.
25. Liu Y., Berthier-Schaad Y., Fallin M.D., Fink N.E., Tracy R.P., Klag M.J., et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006, 17:863-870.
26. Khawaja F.J., Rihal C.S., Lennon R.J., Holmes D.R., Prasad A. Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients